Evidence map›Paper›PMID 23062884›Full record

ArticleDNA repair2012

Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.

Eugene Izumchenko, John Saydi, Kevin D Brown

Abstract read
In one paragraph

Article in DNA repair, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Eugene IzumchenkoDepartment of Biochemistry and Molecular Biology and the UF-Shands Cancer Center, University of Florida College of Medicine, Gainesville, FL 32610, USA.
John Saydi
Kevin D Brown
University of Florida Health · USFlorida College · US

Funding

TRAINING IN THE CELL BIOLOGY AND IMMUNOBIOLOGY OF CANCERT32CA009126 · NCI · UNIVERSITY OF FLORIDA · PI MAY, WILLIAM STRATFORD · 1985 to 2012
$3.5M
Nitrosourea-induced growth arrest and apoptotic pathwaysR01CA102289 · NCI · UNIVERSITY OF FLORIDA · PI BROWN, KEVIN D · 2004 to 2007
$900k
NCI NIH HHS 5T32-CA9126NCI NIH HHS R01 CA102289NCI NIH HHS R01-CA102289NCI NIH HHS T32 CA009126
6 · The paper itself

Abstract

S(N)1 DNA methylating agents are genotoxic agents that methylate numerous nucleophilic centers within DNA including the O(6) position of guanine (O(6)meG). Methylation of this extracyclic oxygen forces mispairing with thymine during DNA replication. The mismatch repair (MMR) system recognizes these O(6)meG:T mispairs and is required to activate DNA damage response (DDR). Exonuclease I (EXO1) is a key component of MMR by resecting the damaged strand; however, whether EXO1 is required to activate MMR-dependent DDR remains unknown. Here we show that knockdown of the mouse ortholog (mExo1) in mouse embryonic fibroblasts (MEFs) results in decreased G2/M checkpoint response, limited effects on cell proliferation, and increased cell viability following exposure to the S(N)1 methylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), establishing a phenotype paralleling MMR deficiency. MNNG treatment induced formation of γ-H2AX foci with which EXO1 co-localized in MEFs, but mExo1-depleted MEFs displayed a significant diminishment of γ-H2AX foci formation. mExo1 depletion also reduced MSH2 association with DNA duplexes containing G:T mismatches in vitro, decreased MSH2 association with alkylated chromatin in vivo, and abrogated MNNG-induced MSH2/CHK1 interaction. To determine if nuclease activity is required to activate DDR we stably overexpressed a nuclease defective form of human EXO1 (hEXO1) in mExo1-depleted MEFs. These experiments indicated that expression of wildtype and catalytically null hEXO1 was able to restore normal response to MNNG. This study indicates that EXO1 is required to activate MMR-dependent DDR in response to S(N)1 methylating agents; however, this function of EXO1 is independent of its nucleolytic activity.

Indexed as

DNA Mismatch RepairAlkylating AgentsAnimalsBase Pair MismatchCell ProliferationCell SurvivalCheckpoint Kinase 1ChromatinCloning, MolecularDNA, ComplementaryDNA MethylationDNA Repair EnzymesExodeoxyribonucleasesFibroblastsG2 Phase Cell Cycle CheckpointsGenetic VectorsAlkylating AgentsCheckpoint Kinase 1CHEK1 protein, humanChek1 protein, mouseChromatinDNA, ComplementaryDNA Repair EnzymesEXO1 protein, humanExodeoxyribonucleasesgamma-H2AX protein, mouseHistonesMethylnitronitrosoguanidineMsh2 protein, mouseMutS Homolog 2 ProteinProtein KinasesRecombinant Proteins

Identifiers

PMID23062884
PMCPMC3505598
OpenAlexW1973255171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.